Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
ESMO Open|June 4, 2023
Cancer care in transgender and gender-diverse persons: results from two national surveys among providers and health service users by the Italian Association of Medical OncologyA G Leone, R Miceli, D Trapani, et al.
Human Reproduction (Oxford, England)|February 27, 2022
Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysisL Arecco, E Blondeaux, M Bruzzone, et al.
ESMO Open|July 3, 2021
The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey IIK H J Lim, K Murali, K Kamposioras, et al.
ESMO Open|June 12, 2026
Long-term outcomes and treatment response in early-stage invasive lobular carcinoma: insights from a nationwide population-based studyG Nader-Marta, L Ameye, D Martins-Branco, et al.
ESMO Open|February 18, 2021
The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaborationS Banerjee, K H J Lim, K Murali, et al.
ESMO Open|April 10, 2021
Impact of COVID-19 on social media as perceived by the oncology community: results from a survey in collaboration with the European Society for Medical Oncology (ESMO) and the OncoAlert NetworkG Morgan, M Tagliamento, M Lambertini, et al.
ESMO Open|January 22, 2025
Factors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real worldE Blondeaux, L Boni, G Chilà, et al.
Journal of Assisted Reproduction and Genetics|January 15, 2022
Installing oncofertility programs for breast cancer in limited versus optimum resource settings: Empirical data from 39 surveyed centers in Repro-Can-OPEN Study Part I & IIMahmoud Salama, M Lambertini, M S Christianson, et al.
ESMO Open|January 10, 2022
The impact of COVID-19 on oncology professionals-one year on: lessons learned from the ESMO Resilience Task Force survey seriesK H J Lim, K Murali, E Thorne, et al.
ESMO Open|February 15, 2023
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literatureA Boutros, A Bottini, G Rossi, et al.
Pageof 7